Gram Research analysis of a 2026 study found that a fermented kefir and yacon drink significantly lowered blood pressure in high-pressure rats over eight weeks, bringing readings close to those of healthy rats (p < 0.05). The results come from animal testing and have not yet been confirmed in people.
Gram Research analysis of a 2026 study in the Journal of Food Science found that a fermented drink made from kefir and yacon, a sweet root vegetable, lowered blood pressure in rats bred to have high blood pressure. Over eight weeks, the drink brought their readings close to those of healthy rats. It also reduced heart enlargement, eased signs of cell damage and inflammation, and increased helpful gut bacteria. These results come from animal testing only. Scientists still need to test the drink in people before anyone can know whether it would help human blood pressure.
Key Statistics
A 2026 animal study published in the Journal of Food Science found that a fermented kefir-yacon drink significantly lowered systolic, diastolic, and mean arterial blood pressure in spontaneously hypertensive rats over eight weeks, bringing values close to those of healthy rats (p < 0.05).
In the same 2026 rat study, the fermented kefir-yacon drink significantly reduced plasma TNF-α and IL-6, two markers of inflammation, compared with untreated high-pressure rats (p < 0.05).
The 2026 study reported that the drink increased fecal counts of Bifidobacterium and Lactobacillus, two beneficial gut bacteria groups, in rats treated for eight weeks.
The Quick Take
- What they studied: Can a fermented drink made from kefir (a probiotic milk drink) and yacon (a sweet tuber) help lower high blood pressure by reducing cell damage, inflammation, and harmful changes in gut bacteria?
- Who participated: Laboratory rats. Some were bred to have high blood pressure, and others had normal blood pressure. The paper does not report how many rats were used. The study divided them into four groups and gave each group a different treatment for eight weeks.
- Key finding: The kefir-yacon drink significantly lowered all three blood pressure measurements in high-pressure rats, bringing them close to the levels seen in healthy rats. The difference was statistically significant (p < 0.05), which means it was unlikely to be due to chance alone.
- What it means for you: This research does not show that the drink works in people. It suggests that a fermented kefir and yacon drink may be worth studying as a possible support for healthy blood pressure. Anyone with high blood pressure should keep taking prescribed medicine and talk with a doctor before changing their diet in a major way.
The Research Details
Researchers used spontaneously hypertensive rats (SHR), a strain that naturally develops high blood pressure, along with Wistar rats, which have normal blood pressure. The animals were split into four groups. One group of healthy Wistar rats received a plain liquid with no active ingredients (the control). One group of high-pressure rats also received the plain liquid. A third group of high-pressure rats received unfermented yacon, and a fourth group received the fermented kefir-yacon drink. Treatments were given by mouth every day for eight weeks.
At the end of the study, the team measured blood pressure and heart rate. They also examined heart tissue for signs of thickening and damage, and measured chemicals linked to oxidative stress, which is cell damage caused by unstable molecules. They checked antioxidant enzymes that help protect cells, along with inflammatory signals such as TNF-α and IL-6. Finally, they counted certain bacteria in the animals’ stool to see how the drink affected gut microbes.
Comparing the four groups side by side allowed the researchers to tell whether the drink made a difference beyond what happened to the untreated high-pressure rats and the healthy rats. The untreated high-pressure group served as the main point of comparison.
Using animal models lets researchers control diet, genetics, and daily routine, and they can examine heart and blood tissue in ways that are not safe in people. Comparing the drink group with both the untreated high-pressure group and the healthy group shows whether any change moved the rats toward normal health. This makes the study useful for generating ideas, but it is still an early step before human trials.
The study reports statistical significance (p < 0.05) for its main blood pressure and inflammation results, and it measured several connected pathways, which strengthens the overall picture. However, the paper does not state how many rats were in each group, which makes it harder to judge how reliable the numbers are. It is also unclear whether the animals were randomly assigned to groups, and the study has not yet been repeated by independent teams. Rat research often does not translate directly to human health, so the results should be read as early evidence only.
What the Results Show
The most important result was the change in blood pressure. In rats with high blood pressure, the kefir-yacon drink significantly reduced systolic pressure (the top number), diastolic pressure (the bottom number), and mean arterial pressure (an average of the pressure throughout the heart cycle). According to the paper, the drink brought these values to levels similar to those of healthy rats.
The researchers also found that the drink reduced heart rate and cardiac hypertrophy, which is the abnormal thickening of the heart muscle that often develops with long-term high blood pressure. This suggests the drink may have protected the heart from some of the strain caused by high pressure.
The drink appeared to work partly by protecting cells from damage. In heart tissue, it increased Nrf2, a protein that switches on the body’s own defense system. It also boosted two antioxidant enzymes, SOD and CAT, which help neutralize unstable molecules. At the same time, it reduced lipid peroxidation (TBARS), a marker of fats being damaged by oxidative stress, and lowered NF-κB, a signal that drives inflammation.
Inflammation levels also dropped. Plasma concentrations of TNF-α and IL-6, two inflammatory messengers in the blood, decreased significantly (p < 0.05). Together, these changes suggest the drink may calm the body’s inflammatory response, which is thought to contribute to high blood pressure.
The team reported that the drink increased fecal counts of Bifidobacterium and Lactobacillus, two groups of bacteria often called beneficial or probiotic. This suggests the drink may shift the balance of gut microbes, which some researchers believe plays a role in blood pressure regulation. Because the paper reports these counts without giving detailed percentages in the abstract, the size of the effect is not clear. Gut bacteria changes are also an area where animal results do not always carry over to people.
Previous research has linked high blood pressure with oxidative stress, chronic inflammation, and gut microbiota imbalance. Studies on fermented foods such as kefir have also suggested possible benefits for heart health and gut balance. This study adds to that work by combining kefir with yacon, a prebiotic root that feeds beneficial bacteria, and testing the drink as a single synbiotic product. It fits the broader idea that foods which calm inflammation and support gut bacteria may help blood pressure, though this specific product has only been tested in rats so far.
The most important limitation is that the study used rats, not people. Rat blood pressure, heart structure, and gut bacteria differ from human ones, so the results may not apply directly. The abstract does not report the number of animals per group, the exact dose of the drink, or whether the drink was compared against a standard blood pressure medicine. It also remains unclear how long the benefits lasted after the treatment stopped. Because the study covered only eight weeks, it says nothing about long-term safety or effects. Finally, the researchers themselves describe the drink as a possible complementary strategy, not a replacement for medical treatment.
The Bottom Line
Based on this single animal study, the evidence is early and preliminary. Confidence that the drink lowers blood pressure in humans is currently low. Confidence that it affects blood pressure in rats is moderate, since the effect was measured and reported as statistically significant. People interested in the drink should treat it as a topic to watch for future human trials rather than a proven treatment. Anyone managing high blood pressure should follow the advice of their own healthcare provider.
People with high blood pressure, researchers who study functional foods, and food scientists developing fermented beverages may find this study especially relevant. People who take blood pressure medicine should not change or stop their medication based on this research. Anyone with kidney problems, diabetes, digestive conditions, or allergies to dairy or specific foods should check with a doctor before trying any new fermented drink.
Human studies would be needed before any benefit could be confirmed. Such trials typically take several months to a year or more to show whether blood pressure changes are lasting. Even in this rat study, the blood pressure changes appeared over an eight-week treatment period. Anyone interested in trying the drink should not expect immediate or guaranteed results, and should not treat it as a substitute for prescribed care.
Frequently Asked Questions
Does kefir and yacon drink lower blood pressure?
In a 2026 rat study, a fermented kefir-yacon drink significantly lowered blood pressure over eight weeks, bringing high-pressure rats close to healthy levels. Human effects have not been tested, so this result cannot yet be applied to people.
What is yacon and why is it used with kefir?
Yacon is a sweet root vegetable from the Andes that contains prebiotic fibers, which feed helpful gut bacteria. In the study, combining yacon with kefir created a synbiotic drink, meaning it supplies both probiotics and the food those microbes need.
Can I replace blood pressure medication with a fermented drink?
No single food has been proven to replace prescribed blood pressure medicine. The kefir-yacon study was done in rats and did not test human safety or effectiveness. Anyone with high blood pressure should continue prescribed treatment and consult a doctor before making changes.
How long did the rat study on kefir-yacon drink last?
The study gave treatments by mouth every day for eight weeks. Researchers then measured blood pressure, heart tissue changes, inflammation markers, and gut bacteria. The paper does not report how long any benefits lasted after treatment stopped.
Want to Apply This Research?
- Record morning and evening blood pressure readings using a validated home monitor, noting systolic and diastolic values. Also log any fermented drinks consumed, the amount in milliliters, and the time of day. Review weekly averages rather than single readings, since daily blood pressure naturally varies.
- If you choose to try a fermented, probiotic-rich drink as part of a balanced diet, add a small serving to your daily routine and track how you feel. Pair it with other habits that support healthy blood pressure, such as reducing salt, eating more vegetables, staying active, and sleeping well. Always check with your doctor before adding a new product, especially if you take medicine.
- Keep a long-term log of blood pressure, heart rate, and daily dietary choices, and share the data with your healthcare provider at regular visits. Look for trends over several months rather than short-term changes. If you begin any new product, record it so you and your doctor can judge whether any changes in readings are connected to it.
This article summarizes an animal study in rats and is for general information only. The findings have not been confirmed in humans, and this content is not medical advice. Do not start, stop, or change any blood pressure medication or treatment without consulting a qualified healthcare provider. If you have concerns about your blood pressure, seek care from a doctor promptly.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.